Lyme Disease Rash - Search News

Pfizer’s Lyme vaccine shows efficacy

Pfizer and Valneva's Lyme disease vaccine shows 70% efficacy in clinical trial

Pfizer and Valneva's Lyme disease vaccine has shown promising results in clinical trials, paving the way for regulatory approval despite setbacks due to fewer cases than expected, according to the companies.

WWMT on MSN · 1d

Pfizer announces promising trial results for Lyme disease vaccine

· 1d

Pfizer’s Lyme vaccine shows efficacy, but misses key statistical hurdle

· 1d

Pfizer says Lyme disease vaccine is holding promise

Pfizer is working to get approval on a new vaccine that could protect people against Lyme disease.

· 1d

Mixed results for Lyme disease vaccine hit Valneva shares

· 1d

Pfizer to seek FDA approval for Lyme vaccine as CT report shows ticks are more abundant than ever

Wonderwall on MSN

5 stars with Lyme disease

Every year, hundreds of thousands of Americans are diagnosed with Lyme disease, according to the Centers for Disease Control and Prevention (CDC). With symptoms ranging from rashes and stiffness to irregular heartbeats and facial palsy,

21dOpinion

Lyme disease patients turn elsewhere because medicine has failed them (Guest Opinion by Holly Ahern)

Microbiology research responds to medical student's critique of unproven alternative treatments. One-size-fits-all medical guidelines are not based on the full spectrum of evidence.

19h

New Lyme disease vaccine tests not as successful as hoped but companies to seek federal approval

The companies said the vaccine was 73% effective in reducing the rate of Lyme disease 28 days after the fourth dose.